Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaccinex IncfiledCriticalVaccinex Inc
Publication of AR120991A1publicationCriticalpatent/AR120991A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Peptides Or Proteins
(AREA)
Abstract
La presente descripción se refiere a anticuerpos o partes de unión al antígeno de estos que se unen específicamente a CCR8 humano, polinucleótidos y vectores que los codifican, y composiciones farmacéuticas que los comprenden. Algunos aspectos de la descripción se refieren a métodos para tratar una enfermedad o afección que comprenden la administración del anticuerpo anti-CCR8 a un sujeto que lo necesite.The present disclosure relates to antibodies or antigen-binding portions thereof that specifically bind to human CCR8, polynucleotides and vectors encoding them, and pharmaceutical compositions comprising them. Some aspects of the disclosure relate to methods of treating a disease or condition comprising administering the anti-CCR8 antibody to a subject in need thereof.
ARP210100018A2020-01-062021-01-06
ANTI-CCR8 ANTIBODIES AND THEIR USES
AR120991A1
(en)